BioAge Labs Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
89
- Stock Symbol
-
BIOA
- Share Price
-
$18.09
- (As of Wednesday Closing)
BioAge Labs General Information
Description
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.
Contact Information
Website
www.bioagelabs.comCorporate Office
- 1445A South 50th Street
- Richmond, CA 94804
- United States
Corporate Office
- 1445A South 50th Street
- Richmond, CA 94804
- United States
BioAge Labs Stock Performance
As of 04-Dec-2024, BioAge Labs’s stock price is $18.09. Its current market cap is $649M with 35.8M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.09 | $17.28 | $16.30 - $26.62 | $649M | 35.8M | 410K | -$24.16 |
BioAge Labs Financials Summary
As of 30-Jun-2024, BioAge Labs has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| Revenue | 0 | 0 | ||
| EBITDA | (58,329) | (39,817) | ||
| Net Income | (63,854) | (39,722) | ||
| Total Assets | 164,402 | 164,402 | 25,924 | 28,429 |
| Total Debt | 0 | 0 | 53,252 | 2,468 |
BioAge Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioAge Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
BioAge Labs Comparisons
Industry
Financing
Details
BioAge Labs Competitors (21)
One of BioAge Labs’s 21 competitors is OrphAI Therapeutics, a Venture Capital-Backed company based in New Haven, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| OrphAI Therapeutics | Venture Capital-Backed | New Haven, CT | ||||
| Alkahest | Formerly VC-backed | San Carlos, CA | ||||
| PlantForm | Venture Capital-Backed | Toronto, Canada | ||||
| Calico | Venture Capital-Backed | San Francisco, CA | ||||
| Avidity Biosciences | Formerly VC-backed | San Diego, CA |
BioAge Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioAge Labs Patents
BioAge Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240366602-A1 | Combination therapy of apelin receptor agonist and glp-1 receptor agonist for treating a disease or condition associated with weight gain | Pending | 03-Jan-2023 | ||
| US-20240122926-A1 | Apelin receptor modulators for treating muscle conditions | Pending | 27-Sep-2022 | ||
| US-20240116933-A1 | Indazole and pyrazolopyridine compounds as inhibitors of nlrp3 inflammasome | Pending | 20-Sep-2022 | ||
| US-20240041878-A1 | Apelin receptor modulators for treatment of a disorder or disease associated with bbb permeability | Pending | 31-May-2022 | ||
| AU-2023281539-A1 | Apelin receptor modulators for treatment of a disorder or disease associated with bbb permeability | Pending | 31-May-2022 |
BioAge Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioAge Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioAge Labs FAQs
-
When was BioAge Labs founded?
BioAge Labs was founded in 2015.
-
Where is BioAge Labs headquartered?
BioAge Labs is headquartered in Richmond, CA.
-
What is the size of BioAge Labs?
BioAge Labs has 89 total employees.
-
What industry is BioAge Labs in?
BioAge Labs’s primary industry is Drug Discovery.
-
Is BioAge Labs a private or public company?
BioAge Labs is a Public company.
-
What is BioAge Labs’s stock symbol?
The ticker symbol for BioAge Labs is BIOA.
-
What is the current stock price of BioAge Labs?
As of 04-Dec-2024 the stock price of BioAge Labs is $18.09.
-
What is the current market cap of BioAge Labs?
The current market capitalization of BioAge Labs is $649M.
-
Who are BioAge Labs’s competitors?
OrphAI Therapeutics, Alkahest, PlantForm, Calico, and Avidity Biosciences are some of the 21 competitors of BioAge Labs.
-
What is BioAge Labs’s annual earnings per share (EPS)?
BioAge Labs’s EPS for 12 months was -$24.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
